Frank J. Kiesner, J.d

Biography

 Mr. Kiesner served as Chairman, President and CEO of Oncotech Inc. for 17 years. Oncotech became the leading company in the USA and Europe in the field of individualizing cancer treatment and drug selection. On a base of $3 million new investment, Mr. Kiesner built the company to this leadership position using only internally generated cash flow and profits. Under his leadership Oncotech validated, introduced and was reimbursed for over 50 new cancer tests. Mr. Kiesner was previously a partner at Northstar Ventures, General Council and Treasurer of ADC Telecommunications (a multi-billion dollar public company) and President of ADC Corporation's Magnetic Division. He served on multiple committees and boards for the American Laboratory Association and has extensive experience in the regional, federal and congressional workings of health care reimbursement. Working with Congressman Bill Thomas, Chairman of the Congress's Ways and Means Sub-Committee on Health, Mr. Kiesner was the leading force behind the passage of the "Patients Benefit Improvement Act Of 1999" which rewrote the new technology approval and patient-provider appellate process for the Medicare and other federal Statutory Programs. Mr. Kiesner obtained his J.D. from the University of Minnesota School of Law.

Research Interest

  Oncotech